Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin for NASH in Adolescents with T1DM
NCT06348706Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin in Nonalcoholic steatohepatitis (NASH), sponsored by Ain Shams University. Started Nov 2022; status: completed.
02
Drugs
vildagliptin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT06348706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06348706.